Protocol for the safety of brodalumab regarding psychiatric comorbidities in patients with psoriasis

INTRODUCTION: Brodalumab, an anti-IL17RA monoclonal antibody, is a treatment option for plaque psoriasis related to increased risk of suicidal ideation and behavior, including completed suicide.However, in the literature no causal relationship is reported, and the reported incidence of patients rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Pikou, O., Argitis, P., Karampas, A., Karavia, S., Chaviaras, Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567734/
http://dx.doi.org/10.1192/j.eurpsy.2022.1957

Ejemplares similares

Ejemplares similares